Hydro One Limited Board of Directors appoints Harry Taylor as Interim President and CEO as David Lebeter takes a temporary compassionate care leave
Prnewswire· 2025-08-14 19:30
Board also appoints Michael W. Rencheck to its Board of DirectorsTORONTO, Aug. 14, 2025 /PRNewswire/ - Today, Hydro One Limited (Hydro One) announced that David Lebeter, President and CEO, will take a temporary compassionate care leave, effective August 25, 2025, to care for a family member. Mr. Lebeter will continue to support the company on an advisory basis until his return. The Board of Directors has appointed Harry Taylor as Interim President and CEO. Mr. Taylor will also continue to serve as EVP, Chie ...
KOIL Energy Reports Second Quarter 2025 Results and Provides a Business Update
Globenewswire· 2025-08-14 19:30
- Revenue of $5.2 million- Gross margin of 33%- Adjusted EBITDA margin of 3%- Awarded three new projects HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Koil Energy Solutions, Inc. (OTCQB: KLNG), a specialist in deepwater energy production and distribution equipment and services, released today its second quarter 2025 results and announced three new projects. “After a modest first half of 2025, momentum is building. Today, we announced three new projects, and recent weeks have brought a sharp rise in service act ...
PagBank reports net revenue of R$5.1 billion and recurring net income of R$565 million in 2Q25
Prnewswire· 2025-08-14 19:30
Banking revenue up 61% y/y, now representing 26% of gross profitSÃO PAULO, Aug. 14, 2025 /PRNewswire/ -- Pagbank (NYSE: PAGS), a leading digital bank offering a comprehensive suite of financial services and payment solutions – always searching to make the financial lives of people and businesses easier – closed the second quarter of 2025 (2Q25) with net revenue of R$5.1 billion, recording growth of 18% when excluding the foreign exchange effect. The results were driven by the strong performance of the banki ...
LM Funding America, Inc. Reports Second Quarter 2025 Financial Results
Globenewswire· 2025-08-14 19:30
- Definitive asset purchase agreement for 11 MW Bitcoin mining site in Mississippi- Direct mining margin improved to 41.0% from 38.5% in Q1 2025- $0.1 million GAAP net income and $2.6M Core EBITDA, up from sequential $5.4 million net loss and $2.8 million negative Core EBITDA in Q1 2025, respectively- Held 150.4 Bitcoin on July 31, 2025 valued at approximately $18.0 million, as of August 11, 2025 TAMPA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Com ...
MiNK Therapeutics Reports Clinical and Strategic Milestones and Second Quarter 2025 Results
Globenewswire· 2025-08-14 19:30
Cash runway extended to deliver clinical program in GVHD and Ph2 results in 2L Gastric CancerDepartment of Defense STTR Grant to advance INKTs in GVHD announced; program advancingNew clinical grant awarded to launch AgenT-797 in GvHD clinical trial; target initiation 2H2025 NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf invariant natural killer T (iNKT) cell therapies, today announced financi ...
FUNDAMENTAL GLOBAL INC. STRENGTHENS BOARD OF DIRECTORS WITH APPOINTMENT OF BLOCKCHAIN PIONEER MAJA VUJINOVIC AND SUCESSFUL SERIAL ENTERPRENEUR & VENTURE CAPITALIST JOSE VARGAS
Globenewswire· 2025-08-14 19:30
Strategic Leadership Additions Reinforce Company's Ethereum Treasury Strategy and Public Markets Expertise Charlotte, NC, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Fundamental Global Inc. (Nasdaq: FGNX, FGNXP) (the “Company” or “FG Nexus”), the premier Ethereum pure-play treasury company, today announced the appointment of two distinguished industry leaders to its Board of Directors: Maja Vujinovic, CEO of Digital Assets, and Jose Vargas, Head of Business Development. "These strategic Board appointments bring toget ...
MiniLuxe Announces Completion of Planned Share Issuance for the Purposes of Acquiring a New Studio Location in Dallas, Texas
GlobeNewswire News Room· 2025-08-14 19:30
Company Continues its Expansion with a New Prime Studio Location and Experienced Team in Dallas Fort Worth’s Lakewood Area NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Boston, MA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- MiniLuxe Holding Corp. (TSXV: MNLX) (“MiniLuxe” or the “Company”) is pleased to announce that, further to its press release dated August 11, 2025, it has completed (with the approval of the TSXV) the issuance a total of 437,500 Class A subor ...
If I Had $50,000 Today - 3 Elite Dividend Stocks I'd Buy Without Hesitation
Seeking Alpha· 2025-08-14 19:30
Join iREIT on Alpha today to get the most in-depth research that includes REITs, mREITs, Preferreds, BDCs, MLPs, ETFs, and other income alternatives. 438 testimonials and most are 5 stars. Nothing to lose with our FREE 2-week trial .Especially during the first half, when elevated volatility hit the market, I used the opportunity to substantially boost some of my favorite holdings.Analyst’s Disclosure:I/we have a beneficial long position in the shares of LB, UNP, CP, CSL either through stock ownership, optio ...
Edible Garden Delivers Strong Performance Across Core and Key Segments, Driven by Strategic Portfolio Transformation
Globenewswire· 2025-08-14 19:30
Company exits low-margin product lines, invests in higher-margin, innovative CEA-informed, better-for-you shelf-stable products, and expands global reach Conference Call to Be Held Today at 8:00 am ET. BELVIDERE, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, better-for-you, sustainable produce and products, today reported strong core business perfor ...
Lexeo Therapeutics Reports Second Quarter 2025 Financial Results and Operational Highlights
GlobeNewswire News Room· 2025-08-14 19:30
Breakthrough Therapy designation granted for LX2006 based on interim data from Phase I/II trials demonstrating clinically meaningful improvements in cardiac and neurologic measures of Friedreich ataxia LX2006 selected for FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot (CDRP) program, created to facilitate CMC registrational readiness and support faster patient access Eight participants dosed in Phase I/II clinical trial (HEROIC-PKP2) of LX2020 for PKP2-ACM; interim clinical data ...